We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




A First: Using Graphene to Detect Cancer Cells

By LabMedica International staff writers
Posted on 27 Dec 2016
Using Raman spectroscopy in developing a new technology that could improve diagnosis and monitoring of cancer, researchers have, for the first time, successfully used graphene to distinguish cancer from healthy cells. More...
The system could potentially also be used to distinguish between various other cell types or cell activities.

By interfacing brain cells onto graphene, researchers at the University of Illinois at Chicago (Chicago, IL, USA) have shown they can differentiate a single hyperactive cancerous cell from a normal cell, pointing the way to developing a non- or less invasive tool for early cancer diagnosis. “This graphene system is able to detect the level of activity of an interfaced cell,” said Vikas Berry, associate professor at UIC, who led the research along with Ankit Mehta, assistant professor at UIC College of Medicine.

“Graphene is the thinnest known material and is very sensitive to whatever happens on its surface,” added Prof. Berry. The nanomaterial is composed of a single layer of carbon atoms linked in a hexagonal chicken-wire pattern, and all the atoms share a cloud of electrons moving freely about the surface. “The cell’s interface with graphene rearranges the charge distribution in graphene, which modifies the energy of atomic vibration as detected by Raman spectroscopy,” he explained. Raman spectroscopy is routinely used to study graphene. The atomic vibration energy in graphene’s crystal lattice differs depending on whether it’s in contact with a cancer cell or a normal cell because the cancer cell’s hyperactivity leads to a higher negative charge on its surface and the release of more protons. The electric field around the cell pushes away electrons in graphene’s electron cloud, which changes the vibration energy of the carbon atoms. The change in vibration energy can be pinpointed by Raman mapping with a resolution of 300 nanometers allowing characterization of the activity of a single cell.

Recently, Prof. Berry and other coworkers had introduced nanoscale ripples in graphene, causing it to conduct differently in perpendicular directions, useful for electronics. They wrinkled the graphene by draping it over a string of rod-shaped bacteria, then vacuum-shrinking the germs. “We took the earlier work and sort of flipped it over,” said Prof. Berry, “Instead of laying graphene on cells, we laid cells on graphene and studied graphene’s atomic vibrations.”

The new study examined cultured human brain cells, comparing normal astrocytes to their cancerous counterpart, the highly malignant brain tumor glioblastoma multiforme. The technique is now being studied in a mouse model of cancer, with results that are “very promising,” said Prof. Berry. Experiments with patient biopsies would be further down the road.

“Once a patient has brain tumor surgery, we could use this technique to see if the tumor relapses,” said Prof. Berry, “For this, we would need a cell sample we could interface with graphene and look to see if cancer cells are still present.”

The same technique may also work to differentiate between other types of cells or the activity of cells. “We may be able to use it with bacteria to quickly see if the strain is Gram-positive or Gram-negative,” said Prof. Berry, “We may be able to use it to detect sickle cells.”

The study, by Keisham B et al, was published November 14, 2016, in the journal ACS Applied Materials and Interfaces.

Related Links:
University of Illinois at Chicago


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
ESR Analyzer
TEST1 2.0
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.